Researchers evaluated the effectiveness of diabetic diets containing D-allulose among type 2 diabetes patients.
Novo Nordisk takes $816M writedown after Phase 3 fail in chronic kidney disease
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS